Information Journal Paper
APA:
CopyFREYER, G., BOSSARD, N., ROMESTAING, P., MORNEX, F., CHAPET, O., TRILLET LENOIR, V., & GERARD, J.P.. (2001). ADDITION OF OXALIPLATIN TO CONTINUOUS FLUOROURACIL, L-FOLINIC ACID, AND CONCOMITANT RADIOTHERAPY IN RECTAL CANCER: THE LYON R 97-03 PHASE I TRIAL. JOURNAL OF CLINICAL ONCOLOGY, 19(9), 2433-2443. SID. https://sid.ir/paper/542905/en
Vancouver:
CopyFREYER G., BOSSARD N., ROMESTAING P., MORNEX F., CHAPET O., TRILLET LENOIR V., GERARD J.P.. ADDITION OF OXALIPLATIN TO CONTINUOUS FLUOROURACIL, L-FOLINIC ACID, AND CONCOMITANT RADIOTHERAPY IN RECTAL CANCER: THE LYON R 97-03 PHASE I TRIAL. JOURNAL OF CLINICAL ONCOLOGY[Internet]. 2001;19(9):2433-2443. Available from: https://sid.ir/paper/542905/en
IEEE:
CopyG. FREYER, N. BOSSARD, P. ROMESTAING, F. MORNEX, O. CHAPET, V. TRILLET LENOIR, and J.P. GERARD, “ADDITION OF OXALIPLATIN TO CONTINUOUS FLUOROURACIL, L-FOLINIC ACID, AND CONCOMITANT RADIOTHERAPY IN RECTAL CANCER: THE LYON R 97-03 PHASE I TRIAL,” JOURNAL OF CLINICAL ONCOLOGY, vol. 19, no. 9, pp. 2433–2443, 2001, [Online]. Available: https://sid.ir/paper/542905/en